Press Release Forum [] Forum Index

Press Release Forum []
Free Press Release Distribution

A site of EPR Network

 FAQFAQ   SearchSearch   MemberlistMemberlist   UsergroupsUsergroups   RegisterRegister 
 ProfileProfile   Log in to check your private messagesLog in to check your private messages   Log inLog in 

Real Time Press Release Distribution is here. Try it out, it's free!


AnaSpec Introduces New Z-Fish™ Anti-Caspase Antibodies

Post new topic   Reply to topic    Press Release Forum [] Forum Index -> Biotech Press Releases
View previous topic :: View next topic  
Author Message

Joined: 15 Aug 2006
Posts: 238
Location: 34801 Campus Drive, Fremont, CA 94555

PostPosted: Thu Jul 16, 2009 2:24 pm    Post subject: AnaSpec Introduces New Z-Fish™ Anti-Caspase Antibodies Reply with quote

San Jose, CA – July 16, 2009

Zebrafish (Danio rerio) is becoming a widely used experimental model for the study of vertebrate development and embryology, toxicology and genomics. In regards to the field of apoptosis, the zebrafish genome has been found to encode a majority of the components that mediate apoptosis in mammals including humans.1-3 Furthermore, apoptosis-regulating genes, such as the Caspases (cysteine aspartic acid proteases), have been cloned from zebrafish.4

AnaSpec is pleased to provide research tools to keep pace with the growing needs of researchers using zebrafish as an experimental model. AnaSpec’s Z-Fish™ anti-caspase list includes antibodies for Caspase 2, with immunizing peptides derived from the N-terminus (NT) or an internal sequence (IN); Caspase 3a, 3b antibodies targeting specifically the p12 or p17 domains; Caspase 8a, with the immunizing peptide derived from an internal caspase 8a sequence; Caspase 9 for p10 and p37 domains; and Caspase-a (caspy) and Caspase-b (caspy-2). These polyclonal antibodies, raised in rabbits, have been verified in ELISA and western blots using zebrafish lysates (see western blots below). Antibodies are supplied in 150 ul sizes and are enough for 15 mini gels.

The list of Z-Fish™ antibodies includes targets used in apoptosis and autophagy, cell cycle control, cytoskeleton, glucose and energy metabolism, signal transduction, and immunity research.

1. Inohara, N., and G. Núñez Cell Death Differ. 7, 509 (2000).
2. Masumoto, J. et al. J. Biol. Chem. 278, 4268 (2003).
3. Aravind, L. et al. Science 291, 1279 (2001).
4. Yamashita, M. Comp. Biochem. Physiol. Part B 136, 731 (2003).

About AnaSpec

AnaSpec is a leading provider of integrated proteomics solutions to the world’s largest biotech, pharmaceutical, and academic research institutions. With a vision for innovation through synergy, AnaSpec focuses on three core technologies: peptides, detection reagents, and antibodies.

For more information visit

Ping Yang
Marketing Speialist
34801 Campus Drive
Fremont, CA 94555
1-800-452-5530 (Toll free)
1-510-791-9560 (Tel)
1-510-791-9572 (Fax)
Back to top
View user's profile Send private message Send e-mail Visit poster's website
Display posts from previous:   
Post new topic   Reply to topic    Press Release Forum [] Forum Index -> Biotech Press Releases All times are GMT - 4 Hours
Page 1 of 1

Jump to:  
You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum
You cannot vote in polls in this forum

Submit Press Release (Free)Submit Press Release


Editor's pick: